Consistent with previous results, CD8+ subsets and Tregs were associated with improved survival in breast cancer patients, and a significant correlation between CD4+ naive T cell expression and OS was identified in breast cancer subtypes HER2-positive and TN [57]. This evidence concerns the gene ERBB2 and breast carcinoma.